Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye
AssigneePresbyopia Therapies LLC
InventorsGerald Horn, Lee Nordan
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods for the improvement of distance vision. The invention further provides compositions and methods for the treatment of refractive errors of the eye. The invention further provides compositions that preferably comprise aceclidine lyophilized with a cryoprecipitate separate or together with a diluent comprising a cycloplegic agent, a surfactant, and optionally a viscosity enhancer.
Claims24
A method of improving distance vision comprising administering to a subject in need thereof a composition comprising aceclidine at a concentration from about 0.25% to about 2.0% w/v and a cycloplegic agent at a concentration from about 0.025% to about 0.1% w/v, wherein w/v denotes weight by volume.
An ophthalmological composition for the treatment of presbyopia comprising:
- aceclidine at a concentration from about 0.25% to about 2.0% w/v;
- a polyol selected from mannitol, xylitol, sorbitol, isosorbide, and maltitol as a cryoprecipitate;
- and tropicamide at a concentration from about 0.025% to about 0.10% w/v,
- wherein w/v denotes weight by volume.
A method of treating a refractive error of the eye in a subject in need thereof comprising administering to a subject in need thereof a first composition comprising lyophilized aceclidine at a concentration from about 0.25% to about 2.5% w/v and a cryoprecipitate at a concentration from about 2.5% w/v to about 6.0% w/v and further comprising administering concurrently or sequentially a second composition comprising a cycloplegic agent at a concentration from about 0.025% to about 0.1% w/v and optionally one or more excipients selected from a nonionic surfactant at a concentration from about 0.25% to about 10% w/v, a viscosity enhancer, a buffer and a preservative, wherein w/v denotes weight by volume, wherein the refractive error of the eye is selected from presbyopia, myopia, hyperopia, astigmatism or a combination thereof.
A method for treating a refractive error of the eye comprising administering to a patient in need thereof a pharmaceutically acceptable amount of a composition comprising aceclidine at a concentration from about 0.25% to about 2.0% w/v and a cycloplegic agent at a concentration from about 0.025% to about 0.1% w/v, wherein w/v denotes weight by volume, wherein the size of the pupil is reduced to from about 1.5 to about 2.5 millimeters and wherein the refractive error is selected from the group consisting of corneal irregular astigmatism, an ectasia induced corneal irregularity, a pellucid induced corneal irregularity, a higher order aberration and a refractive surgery induced higher order aberration.
An ophthalmological composition for the treatment of presbyopia comprising:
- aceclidine at a concentration of about 1.65% w/v;
- and
- tropicamide at a concentration of about 0.042% w/v,
- wherein w/v denotes weight by volume.
Dependencies are inferred from the claim text.